Available IPD datapackage for study 'A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)'
收藏DataCite Commons2025-10-03 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00006704.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of SHP465 at 6.25 mg in the
treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6-12 years.
提供机构：
Vivli
创建时间：
2025-10-03
